GT Biopharma, Inc. (GTBP) vs Mangoceuticals, Inc. (MGRX)

A side-by-side comparison of GT Biopharma, Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
GT Biopharma, Inc. logo
GTBP
GT Biopharma, Inc.
$8M
$6.26HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Mangoceuticals, Inc. logo
MGRX
Mangoceuticals, Inc.
$7M
$0.42HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

Total return — GTBP vs MGRX

growth of $100 · dividends reinvested · last 4y
GTBP -98.5% (-65.0%/yr)MGRX -99.3% (-71.1%/yr)GTBP compounded faster over this window
050100Start $100202420252026$1$1
GTBP MGRX

GTBP vs MGRX: by the numbers

  • •GTBP is the larger company ($8M vs $7M market cap).
  • •Both run net losses; GTBP's is the smaller (0.00% vs -4791.48% net margin).

Metrics side by side

Valuation

MetricGTBPMGRX
P/S ratioN/A22.85
P/B ratio2.210.58

Profitability

MetricGTBPMGRX
Gross margin0.00%54.43%
Operating margin0.00%-4200.46%
Net margin0.00%-4791.48%
ROE-618.74%-120.58%
ROIC-457.75%-102.91%

Growth (annualized)

MetricGTBPMGRX
Total return CAGR (5Y)-73.13%N/A

Go deeper

Full GTBP analysisFull MGRX analysisInteractive comparison tool

Dig into the metrics

GT Biopharma ROEMangoceuticals ROEGT Biopharma operating marginMangoceuticals operating marginGT Biopharma revenue growthMangoceuticals revenue growthGT Biopharma free cash flowMangoceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.